Edition:
United Kingdom

People: BioTelemetry Inc (BEAT.OQ)

BEAT.OQ on NASDAQ Stock Exchange Global Select Market

46.56USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$46.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
170,860
52-wk High
$80.80
52-wk Low
$46.19

Rietiker, Stephan 

Dr. Stephan Rietiker M.D. is the Director of the Company. Dr. Rietiker was most recently the Chief Executive Officer of LifeWatch, until it was acquired by BioTelemetry in August 2017. Prior to becoming CEO of LifeWatch in 2014, Dr. Rietiker held executive roles at Roche, Boehringer Mannheim, Schering Plough, Covance and as CEO of Centerpulse (formerly Sulzer Medica). In 2006, Dr. Rietiker incorporated AurigaVision AG, a Switzerland-based investment platform that focuses on promising developmental-stage healthcare companies. Additionally, he has been an investor, executive and Board Member of several developmental-stage companies and has been a Senior Advisor to Brown Brothers Harriman’s M&A practice. Since 2014, Dr. Rietiker has been serving on the board of directors for California-based LoneStar Heart, a company developing breakthrough therapies against advanced heart failure. Dr. Rietiker is a dual citizen of both Switzerland and the United States and received his medical doctorate from the University of Zurich in 1982.

Basic Compensation

Total Annual Compensation, USD 9,117
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 9,117

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kirk Gorman

230,658

Joseph Capper

3,875,560

Heather Getz

1,632,580

Fred Broadway

1,007,410

Peter Ferola

917,995

Daniel Wisniewski

935,098
As Of  31 Dec 2018